While a study of esophageal squamous cell carcinoma found that promoter methylation can silence the expression of PRSS3, [29] some other studies reported that methylation of the PRSS3 promoter in bladder cancer, lung cancer, esophageal cancer, and gastric cancer also silence its expression [17, 29–30]. This evidence concerns the gene PRSS3 and urinary bladder cancer.